Aptevo Therapeutics Announces Second Complete Remission in Ongoing APVO436 Phase 1 Clinical Trial
Second Complete Remission Observed in a Patient in Cohort 6 Enrollment in Cohort 8 Has…
Second Complete Remission Observed in a Patient in Cohort 6 Enrollment in Cohort 8 Has…
Not for distribution to United States newswire services or dissemination in the Unites States SUDBURY,…
TORONTO, ON / ACCESSWIRE / November 9, 2020 / Roscan Gold Corporation (“Roscan” or the…
NIAGRA FALLS, ON and ARVIN, CA / ACCESSWIRE / November 9, 2020 / EnerDynamic Hybrid…
SANTA CLARA, CA / ACCESSWIRE / November 9, 2020 / SPI Energy Co., Ltd., (NASDAQ:SPI)…
A national chain of medical marijuana clinics has launched a program to award free MMJ…
CHARLOTTE, NC / ACCESSWIRE / November 9, 2020 / How can investors fund a Self-Directed…
LONDON, UK / ACCESSWIRE / November 9, 2020 / Anglo Pacific Group PLC (“Anglo Pacific”,…
Volunteers from British Telecom (BT), C-DOT, Hyundai Motors and ETSI were presented with Technical Excellence…
Premier support to EBS R12.1 and all earlier versions is being cut off from December…
Report provides an overview of 33 different solutions providers including Boldon James and Titus, both…
The grant has been awarded to Navenio’s ‘Intelligent Workforce Solution’, to mitigate the impact of…
OKLAHOMA CITY, Nov. 09, 2020 (GLOBE NEWSWIRE) — Cytovance® Biologics, a leading biopharmaceutical contract development…
LONDON and RALEIGH, N.C., Nov. 09, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
LIfT BioSciences N-LIfT Cell Therapy Successfully Infiltrates Pancreatic Tumours In-vivo London, 9 November 2020 –LIfT…
OXURION NV Confirms New Patents for THR-687 Issued by European and US Patent Offices Composition-of-matter…
Montrouge, France, November 9, 2020DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies (Euronext:…
November 9, 2020 Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX),…
Geneva, Switzerland and Boston, MA – November 9, 2020 – ObsEva SA (NASDAQ: OBSV…
Orphazyme A/SCompany announcement …